DocuSign Is Back at the Price Private Equity Walked Away From

In December 2023, the Wall Street Journal reported that DocuSign, the electronic-signature company, was exploring a sale to private equity, and the stock jumped about 14% in a day, to roughly $64. Today, roughly three years later, DocuSign trades at roughly $64. That is weird.

Everything underneath the stock got better in the meantime. In the fiscal year that ended in January, DocuSign brought in $3.2 billion of revenue and earned an adjusted $3.84 per share; a quarter later it reported $830 million in revenue, up 9%, with free cash flow of $289 million in a single quarter — a 35% margin. It has become one of the most aggressive self-buyers in software, repurchasing $869 million of its own stock in fiscal 2026 and another $318 million in the first quarter of fiscal 2027, shrinking its diluted share count by roughly 8% in a year. The market capitalization when the buyout rumor first surfaced was about $11.5 billion. It is about $12.2 billion today.

So three years of growth, buyback-funded share shrinkage, and compounding adjusted earnings — and the equity is worth a rounding error more. The multiple did all the work. The market is not arguing about whether the earnings are real. It is arguing about what kind of company the earnings belong to: a slowly growing cash machine, or an AI story that has not quite happened yet.

The product is a document

DocuSign's actual product is the least glamorous thing in the modern office: the signature, and the contract it seals. Roughly 1.9 million customers pay for the ability to send, sign, and manage agreements, and the economics of the signature business are beautiful — subscription revenue, about an 81% gross margin, and customers who do not really churn, because nobody wants to re-architect how their contracts get signed.

The problem with signatures is that they are a solved problem. Growth compounded well above 40% during the pandemic, when "sign at home" became existential, and has since thrashed down to high single digits: 8% revenue growth in fiscal 2026, with the company guiding to about 9% for the current year, and that is after roughly 1.5 percentage points of currency help.

The company's answer is to argue that the market is classifying it wrong. In April 2024 DocuSign stopped calling itself an e-signature company and announced a "new SaaS category" called Intelligent Agreement Management, or IAM — the idea being that the signatures are the boring part and the document is the interesting part. The signature exists for a moment; the contract lives for years. IAM tries to make the contract the system of record: AI agents that read agreements, summarize them, flag obligations, suggest redlines, and watch for renewals. This is the bet in one sentence: the document, not the signature, is the product, and everyone who signs lots of documents becomes a reason to charge for something bigger.

It is a real thing, not just a deck. IAM represented 2.3% of DocuSign's annual recurring revenue a year and a half ago, 10.8% as of January, and 12.6% as of April — customers using it now account for over $350 million of annual recurring revenue, and the CEO says 40,000 customers are now paying for pieces of it. The stock's entire upside rests on whether that curve keeps climbing quickly enough to turn a ~9% grower into a ~15% grower.

Two earnings, one price

That brings us to the valuation, which is really two valuations, and the gap between them is the entire debate in one accounting line.

On generally accepted accounting principles — where stock-based compensation counts as a real expense, like any other cost — DocuSign trades around 39 times trailing earnings and about 45 times forecast earnings. That is a growth company's multiple attached to a company growing at 9%. On the adjusted (non-GAAP) profit the company and most analysts quote, which adds back roughly a half-billion dollars a year of stock compensation and related charges, it trades around 17 times earnings. One view says "priced like a growth stock without the growth." The other says "cheap for a business with these margins, this cash flow, and this much buyback."

The adjusted number is not fake — the cash flow is real, and a company generating $1 billion a year in free cash flow is genuinely paying for those buybacks in dollars. But the distinction matters: what the company labels "non-GAAP earnings" is profit before one of its largest costs, and that cost is paid in the shares you, the shareholder, are diluted by. If you are comfortable calling that cost "worth it," the stock looks like a bargain cash machine. If you insist on counting it, the stock looks like it is priced for re-acceleration of growth, which is precisely what IAM is supposed to deliver.

The perpetual suitor

None of this is why the stock trades the way it does. The stock trades the way it does because of private equity.

DocuSign has been circled by buyout firms for going on three years. In late 2023 it hired advisers to explore an LBO. In January 2024 Bain Capital and Hellman & Friedman were reported to be the final bidders, with the banks preparing to finance a deal around $13 billion — and then, in February, the talks collapsed over price. The interest re-emerged in late 2025 and again this month, and each wave has given the stock the same shot of adrenaline: up double digits in a day on the rumor, then a slow settle when no deal arrives. Meanwhile the CEO has said plainly that he wants to build "a great, independent public company".

You can sort of see the logic from both sides. To a private equity firm, this is an attractive LBO: high margins, $1 billion of free cash flow, a net cash balance sheet, and an 8% grower that the public market refuses to pay a growth multiple for. The firms walk away because the same thing that makes it attractive in cash terms makes the price negotiation brutal on a low-growth asset. And the public market, unable to settle on a price, keeps doing what it does: it bids the stock up to the mooted buyout price on rumor and sells it back when the rumor fails. The takeover chatter is the market's way of arbitrating the gap between what the business is worth as a cash machine and what it is worth as a growth story — and three years running, the answer has been roughly $12 billion, which is also roughly today's entire market capitalization.

That has a practical consequence for the stock. The buyout speculation puts a floor in the market's imagination when things go wrong, and a ceiling when things go right: nobody expects a real buyer to pay much more than the price the last round of buyers declined. Management, meanwhile, is effectively running its own LBO — spending the cash flow on shrinking the share count while promising to stay public and buy back $2.6 billion more.

Where that leaves you

The stock today is at $64, about 26% below its high of the past year and about 60% above its low. It has rallied about 17% in a month, driven by a bounce in software sentiment, a fresh round of takeover talk, and a new partnership putting DocuSign's agreement technology inside Google Cloud's AI product for legal teams. This is the notable part: the median analyst price target is around $55, below where the stock trades. In other words, the market has already paid the takeover-chatter premium, and the sell-side thinks the excitement overshot the fundamentals.

DocuSign reports fiscal second-quarter results on September 3, and that print is the next time the market gets to choose which frame applies. The number to watch is billings — roughly the value of contracts signed in the quarter, a leading indicator of future revenue, and the metric whose guidance cut sent the stock down 18% in a single day back in June 2025. The second number is ARR growth, guided to about 8.5%. The third is IAM's creeping share of that ARR, the only line item that can convert the "cash machine" frame into something with a growth option in it.

If you step back, the honest summary is: this is a profitable, cash-generative company that the market cannot decide whether to classify as cheap-and-slow or growth-with-a-bet. The price has been remarkably stable for three years precisely because the debate has been stuck, and the reflexive part of that stability is the takeover premium that keeps getting refilled by rumor and drained by reality. The bull case requires IAM to make the growth real. The bear case does not require anything to go wrong with the business — it just requires the growth to stay at 9%, because then you are paying a growth multiple for a cash machine, which is what the private equity firms have so far declined to do.